20150129 smb nemo healthcare
Transcript of 20150129 smb nemo healthcare
Science meets Business Health technology assessment
January 29, 2015 Confidential
Safe births Healthy children
Ambition: What if we could reduce birth asphyxia with 50%?
• Save 20.000 newborns yearly from starting with a handicap
• Deliver €10B cost of care savings to society
• Build a great enterprise with €100M+ revenues
Confidential
Guess what, we can!
But HOW to achieve that goal???
What we believe (and know, of
course...)
1) We are the best, we can do this...
2) Yes, absolutely, you need to invest in us...
3) This is huge...
4) It will be all right, trust me...
Confidential
What ‘they’ see...
Technology development takes (too) long... Underfunded, but they get there: CE marking (2013) They’re halfway there... Now prove they can sell...
Confidential
1) We need users (to prove we can sell)
2) Users want scientific proof
3) We need users to provide scientific proof... See 1)
Confidential
Paradox
Vicious circle
Confidential
How to break these chains?
Health technology assessment
Confidential
MedValue Technology assessment
What can PUREtrace bring:
• Cost savings?
• Reduce C-sections?
• Convince decision makers?
• ...
Confidential
CTG tracing showed drop in FHR (blue arrow), emergency C-section would be logical next step. PUREtrace indicated non-relaxing uterine muscle (red arrow). Oxytocin was stopped and the fetus recovered. Eventually, the child was delivered vaginally (data MMC Veldhoven).
Data from HIS MMC Veldhoven
Confidential
Example
Output • Independent proof
through solid research
• Radboud UMC connected
• Access to insurers
• Validation options
• Network
• ...
Confidential
HTA provides
• Early stage screening
• Early stage proof (at limited costs)
• Independent support
• Improvement plans
Confidential
HISTORY Confidential